Latest News and Press Releases

Detaljerede data fra et randomiseret fase 2 studie med PROSTVAC(TM) blev i dag præsenteret på ASCO Annual Meeting i Orlando i USA. Præsentationen blev afholdt af Professor Philip Kantoff, MD,...

Phase 2 Data Show Partial Responses and Generally Well-Tolerated Safety Profile in Patients with Advanced Non-Small Cell Lung Cancer Phase 1 Study Demonstrates Combinability of IPI-504...

Announcement No. 24-09 / Copenhagen, 30 May 2009 TopoTarget A/S Symbion Fruebjergvej 3 DK 2100 Copenhagen Denmark Tel: +45 39 17 83 92 Fax: +45 39 17 94 92 CVR-nr:...

NASDAQ OMX: GNW Testmessage 20090530 16:07 - TO BE DELETED ...

REDWOOD CITY, Calif., May 30, 2009 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD) today announced clinical trial results related to its clinical stage hypoxia-activated prodrug,...

-- First Clinical Study of Anti-CD74 Antibody -- -- Results Presented At 2009 Annual Meeting of ASCO -- ORLANDO, Fla., May 30, 2009 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a...

Announcement No. 23-09 / Copenhagen, 30 May 2009 TopoTarget A/S Symbion Fruebjergvej 3 DK 2100 Copenhagen Denmark Tel: +45 39 17 83 92 Fax: +45 39 17 94 92 CVR-nr:...

MARLBOROUGH, MA--(Marketwire - May 30, 2009) - Workscape, Inc., a leading provider of outsourced benefits and talent management, will launch a live survey on the business-critical topic of corporate...

NEW YORK, May 29, 2009 (GLOBE NEWSWIRE) -- Gainey & McKenna was the first to file a class action lawsuit in the United States District Court for the Southern District Texas, Dallas Division, on...

YOQNEAM, ISRAEL--(Marketwire - May 29, 2009) - Given Imaging (NASDAQ: GIVN) today announced that the company will host a conference call on June 3, 2009 to review PillCam SB video capsule and Bravo...